The first case of the Lambda variant of the novel coronavirus confirmed in Japan was brought by a woman arriving from Peru for the Tokyo Olympics, government sources said.

A team of Japanese researchers identified a protein that can foretell severe COVID-19 cases, potentially making it possible to determine the severity of a patient's symptoms. Scientists from Chiba ...

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

I first visited Japan in 2020, just before the COVID-19 pandemic began. One evening in Odaiba, I rode the Ferris wheel at Palette Town. (It was taken ...

MANILA, Philippines — Senate President Alan Peter Cayetano on Saturday denied claims that the proposal allowing senators to ...

The FDA’s outside vaccine advisers plan to convene Thursday to recommend which Covid-19 strain vaccine manufacturers should target for the 2026-2027 season’s products, all while the country’s vaccine ...

Japan Prime Minister Yoshihide Suga was still uncertain whether fans can be allowed at the Tokyo Olympics because of growing concern about rising COVID-19 cases on Thursday only three weeks before the ...

Vaccine makers Moderna and Sanofi discussed data on mice research suggesting that vaccines targeting XFG trigger higher antibody concentrations against circulating SARS-CoV-2 strains than Pfizer’s and ...

TOKYO—Japanese officials sounded the alarm on Thursday after Tokyo reported record-breaking coronavirus cases for two straight days with the Olympics well underway. “We have never experienced the ...

This report presents an overview of our business performance and key performance indicators (KPIs) for the first quarter of ...

Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...

AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...